There have been 50 recent insider transactions recorded for Biogen Inc. (BIIB), including 23 buys and 26 sells. Total insider buying was valued at $152.14K and total insider selling at $2.46M.
Notable insiders with recent activity include Godbout Sean, Alexander Susan H, Gregory Ginger. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — BIIB
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-04-01 |
Godbout Sean |
Chief Accounting Officer |
Option Exercise (Sell) |
181 |
- |
- |
364 |
| 2026-02-13 |
Alexander Susan H |
EVP Chief Legal Officer |
RSU Award |
8,450 |
- |
- |
8,450 |
| 2026-02-13 |
Gregory Ginger |
EVP, Human Resources |
RSU Award |
8,025 |
- |
- |
8,025 |
| 2026-02-13 |
Kramer Robin |
Chief Financial Officer |
RSU Award |
8,450 |
- |
- |
8,450 |
| 2026-02-13 |
Singhal Priya |
Head of Development |
RSU Award |
10,560 |
- |
- |
10,560 |
| 2026-02-13 |
Viehbacher Christopher |
President and CEO |
RSU Award |
38,015 |
- |
- |
38,015 |
| 2026-02-13 |
Izzar Rachid |
Head of Global Product Strat. |
RSU Award |
7,390 |
- |
- |
7,390 |
| 2026-02-13 |
Murphy Nicole |
Head of Pharm Ops and Tech |
RSU Award |
10,560 |
- |
- |
10,560 |
| 2026-02-13 |
Keeney Adam |
Head of Corporate Development |
RSU Award |
8,025 |
- |
- |
8,025 |
| 2026-02-13 |
Grogan Jane |
Head of Research |
RSU Award |
8,450 |
- |
- |
8,450 |
| 2026-02-13 |
Godbout Sean |
Chief Accounting Officer |
RSU Award |
1,800 |
- |
- |
1,800 |
| 2026-02-12 |
Murphy Nicole |
Head of Pharm Ops and Tech |
Informative Buy |
3 |
$195.04 |
$585.11 |
19,611 |
| 2026-02-09 |
Singhal Priya |
Head of Development |
Informative Sell |
2,660 |
$199.83 |
$531.55K |
8,043 |
| 2026-02-06 |
Alexander Susan H |
EVP Chief Legal Officer |
Option Exercise (Sell) |
2,190 |
- |
- |
- |
| 2026-02-06 |
Gregory Ginger |
EVP, Human Resources |
Option Exercise (Sell) |
1,635 |
- |
- |
- |
| 2026-02-06 |
Kramer Robin |
Chief Financial Officer |
Option Exercise (Sell) |
789 |
- |
- |
- |
| 2026-02-06 |
Singhal Priya |
Head of Development |
Option Exercise (Sell) |
2,217 |
- |
- |
2,217 |
| 2026-02-06 |
Viehbacher Christopher |
President and CEO |
Option Exercise (Sell) |
9,008 |
- |
- |
9,009 |
| 2026-02-06 |
Izzar Rachid |
Head of Global Product Strat. |
Option Exercise (Sell) |
2,044 |
- |
- |
- |
| 2026-02-06 |
Murphy Nicole |
Head of Pharm Ops and Tech |
Option Exercise (Sell) |
2,102 |
- |
- |
- |
| 2026-02-06 |
Keeney Adam |
Head of Corporate Development |
Option Exercise (Sell) |
1,802 |
- |
- |
1,802 |
| 2026-02-06 |
Grogan Jane |
Head of Research |
Option Exercise (Sell) |
1,385 |
- |
- |
1,385 |
| 2026-02-06 |
Godbout Sean |
Chief Accounting Officer |
Option Exercise (Sell) |
257 |
- |
- |
- |
| 2026-02-02 |
Singhal Priya |
Head of Development |
Informative Sell |
748 |
$179.30 |
$134.12K |
6,271 |
| 2026-01-30 |
Singhal Priya |
Head of Development |
Option Exercise (Sell) |
1,829 |
- |
- |
- |
| 2025-12-01 |
Viehbacher Christopher |
President and CEO |
Option Exercise (Sell) |
7,040 |
- |
- |
- |
| 2025-06-17 |
Sherwin Stephen A |
Director |
RSU Award |
2,370 |
- |
- |
13,688 |
| 2025-06-17 |
Hawkins William A |
Director |
RSU Award |
2,370 |
- |
- |
8,860 |
| 2025-06-17 |
Dorsa Caroline |
Director |
RSU Award |
3,160 |
- |
- |
31,002 |
| 2025-06-17 |
Rowinsky Eric K |
Director |
RSU Award |
2,370 |
- |
- |
24,339 |
| 2025-06-17 |
Freire Maria C |
Director |
RSU Award |
2,370 |
- |
- |
6,815 |
| 2025-06-17 |
Mantas Jesus B |
Director |
RSU Award |
2,370 |
- |
- |
9,758 |
| 2025-06-17 |
Patolawala Monish D |
Director |
RSU Award |
2,370 |
- |
- |
3,710 |
| 2025-06-17 |
Langer Susan |
Director |
RSU Award |
2,370 |
- |
- |
5,129 |
| 2025-06-17 |
Pangalos Menelas N |
Director |
RSU Award |
2,370 |
- |
- |
2,370 |
| 2025-06-17 |
Minor Lloyd |
Director |
RSU Award |
2,370 |
- |
- |
2,370 |
| 2025-05-19 |
Singhal Priya |
Head of Development |
Informative Sell |
3,806 |
$126.25 |
$480.51K |
5,427 |
| 2025-05-02 |
Dorsa Caroline |
Director |
Informative Buy |
1,235 |
$122.72 |
$151.56K |
27,842 |
| 2025-05-01 |
Keeney Adam |
Head of Corporate Development |
Option Exercise (Sell) |
938 |
- |
- |
939 |
| 2025-04-01 |
Godbout Sean |
Chief Accounting Officer |
RSU Award |
545 |
- |
- |
545 |
| 2025-03-07 |
Sherwin Stephen A |
Director |
Informative Sell |
8,760 |
$150.02 |
$1.31M |
11,318 |
| 2025-03-01 |
Godbout Sean |
Chief Accounting Officer |
Unknown |
257 |
- |
- |
- |
| 2025-02-10 |
Mcdonnell Michael R |
EVP, Chief Financial Officer |
Option Exercise (Sell) |
3,257 |
- |
- |
- |
| 2025-02-10 |
Alexander Susan H |
EVP Chief Legal Officer |
Option Exercise (Sell) |
2,575 |
- |
- |
- |
| 2025-02-10 |
Gregory Ginger |
EVP, Human Resources |
Option Exercise (Sell) |
2,159 |
- |
- |
- |
| 2025-02-10 |
Kramer Robin |
Chief Accounting Officer |
Option Exercise (Sell) |
834 |
- |
- |
- |
| 2025-02-10 |
Singhal Priya |
Head of Development |
Option Exercise (Sell) |
1,212 |
- |
- |
- |
| 2025-02-10 |
Izzar Rachid |
Head of Global Product Strat. |
Option Exercise (Sell) |
1,515 |
- |
- |
- |
| 2025-02-10 |
Murphy Nicole |
Head of Pharm Ops and Tech |
Option Exercise (Sell) |
2,272 |
- |
- |
- |
| 2025-02-07 |
Mcdonnell Michael R |
EVP, Chief Financial Officer |
Option Exercise (Sell) |
2,335 |
- |
- |
2,335 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
